<DOC>
	<DOC>NCT02185183</DOC>
	<brief_summary>Oral administration of Alequel, a mixture of proteins derived from the patient's bowel will be tested in patients with inflammatory bowel disease.</brief_summary>
	<brief_title>Oral Administration of AlequelTM for Patients With Inflammatory Bowel Disease (IBD)</brief_title>
	<detailed_description>Oral administration of Alequel prepared from patients biopsies will be tested in patients with inflammatory bowel disease to determine its anti inflammatory effect.</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>Crohn's disease Immune suppression</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>